Thomas King

Thomas King serves as a member of the Board of Directors at TFF Pharmaceuticals, Inc. since December 2023 and is the Chair of the Board of Directors at Kinaset Therapeutics since July 2020, where efforts are focused on developing innovative respiratory therapeutics for severe asthma. Additionally, Thomas King holds the position of Executive Chair at Concentric Analgesics, Inc., which specializes in non-opioid therapeutics for pain management, and serves as an Executive Chair at Achieve Life Sciences, a company dedicated to combating nicotine addiction through the development of cytisinicline. Previous roles include Independent Lead Director at Berkshire Biomedical, Senior Advisor at Satsuma Pharmaceuticals, and Board member at multiple organizations including VIVUS, Inc. and Faraday Pharmaceuticals. Thomas King earned an MBA in Finance from the University of Kansas and has a background in Chemistry from McPherson College and the University of Kansas.